COVID-19 and Drug Shortages: A Call to Action

The ever-vulnerable medication supply chain is being further strained by the COVID-19 pandemic. Pharmacists in all settings, including managed care, will need to prepare for a potential exacerbation of existing and new drug shortages in the midst of unprecedented crisis. We summarize the major issue...

Descripción completa

Detalles Bibliográficos
Autores principales: Shuman, Andrew G., Fox, Erin R., Unguru, Yoram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2020
Materias:
Viewpoints
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391236/
https://www.ncbi.nlm.nih.gov/pubmed/32715960
http://dx.doi.org/10.18553/jmcp.2020.26.8.945
_version_ 1785082659674783744
author Shuman, Andrew G.
Fox, Erin R.
Unguru, Yoram
author_facet Shuman, Andrew G.
Fox, Erin R.
Unguru, Yoram
author_sort Shuman, Andrew G.
collection PubMed
description The ever-vulnerable medication supply chain is being further strained by the COVID-19 pandemic. Pharmacists in all settings, including managed care, will need to prepare for a potential exacerbation of existing and new drug shortages in the midst of unprecedented crisis. We summarize the major issues, discuss potential mitigation strategies, and call on our colleagues to respond with the resilience necessary to protect our patients.
format Online
Article
Text
id pubmed-10391236
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Academy of Managed Care Pharmacy
record_format MEDLINE/PubMed
spelling pubmed-103912362023-08-02 COVID-19 and Drug Shortages: A Call to Action Shuman, Andrew G. Fox, Erin R. Unguru, Yoram J Manag Care Spec Pharm Viewpoints The ever-vulnerable medication supply chain is being further strained by the COVID-19 pandemic. Pharmacists in all settings, including managed care, will need to prepare for a potential exacerbation of existing and new drug shortages in the midst of unprecedented crisis. We summarize the major issues, discuss potential mitigation strategies, and call on our colleagues to respond with the resilience necessary to protect our patients. Academy of Managed Care Pharmacy 2020-08 /pmc/articles/PMC10391236/ /pubmed/32715960 http://dx.doi.org/10.18553/jmcp.2020.26.8.945 Text en Copyright © 2020, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Viewpoints
Shuman, Andrew G.
Fox, Erin R.
Unguru, Yoram
COVID-19 and Drug Shortages: A Call to Action
title COVID-19 and Drug Shortages: A Call to Action
title_full COVID-19 and Drug Shortages: A Call to Action
title_fullStr COVID-19 and Drug Shortages: A Call to Action
title_full_unstemmed COVID-19 and Drug Shortages: A Call to Action
title_short COVID-19 and Drug Shortages: A Call to Action
title_sort covid-19 and drug shortages: a call to action
topic Viewpoints
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391236/
https://www.ncbi.nlm.nih.gov/pubmed/32715960
http://dx.doi.org/10.18553/jmcp.2020.26.8.945
work_keys_str_mv AT shumanandrewg covid19anddrugshortagesacalltoaction
AT foxerinr covid19anddrugshortagesacalltoaction
AT unguruyoram covid19anddrugshortagesacalltoaction

Ejemplares similares